Effect of Propolis Application on Burn Healing

Sponsor
Izmir Katip Celebi University (Other)
Overall Status
Completed
CT.gov ID
NCT04277182
Collaborator
(none)
36
1
6
27
40.6

Study Details

Study Description

Brief Summary

This experimental study will be carried out at Ege University Laboratory Animals Application and Research Center to identify the efficacy of 10% propolis and 15% propolis on wound healing in a second-degree superficial burn wound.

In the study, 36 adult (8-12 week old) Wistar-Albino rats with a weight of 200-300 grams will be used in each group. Each group will include 6 rats. Stratified randomization will be used to randomize rats according to their gender and weight. After randomization, a burnt area will be created on the back of the rats and dressings will be made every day.

Following the creation of the burn, biopsy samples will be taken on the 3rd, 7th, 14th and 21st days and at the light microscopic level; bulla, erythema, oedema, burn depth, inflammatory cell infiltration, necrosis, ulceration, angiogenesis, neovascularization, fibroblast proliferation, collagenization, epithelization, fibrosis, the number of hair follicles and damage to the skin attachments.

In the immunohistochemical examination of biopsy samples, samples will be taken for the evaluation of superoxide dismutase, malondialdehyde, myeloperoxidase in the evaluation of the tumour necrosis factor-alpha, interleukin-1β and oxidative stress in the EBB period in order to evaluate the acute phase reactants. Fungal and gram staining will be done in order to determine the pathogen reproduction in biopsy samples taken on the 3rd and 7th day. Masson trichrome in order to detect fibrosis in biopsy samples taken on the 14th and 21st day; Hydroxyproline examination will be examined in order to evaluate collagen formation.

Condition or Disease Intervention/Treatment Phase
  • Biological: burn wound dressing
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
1st. group: It will be considered as a control group and rats will not be treated. 2nd. group: Vehicle group, Propolis vehicle will be applied to rats for 21 days. 3rd. group: Silver Sulfadiazine group, 1% Silver Sulfadiazine will be applied topically to rats for 21 days. 4th. group: Nitrafurozon group, 0.2% Nitrafurozon will be applied topically for 21 days. 5th. group: 10% Propolis group, 10% Propolis will be applied topically for 21 days. 6th. group: 15% Propolis group, 15% Propolis will be applied topically for 21 days.1st. group: It will be considered as a control group and rats will not be treated. 2nd. group: Vehicle group, Propolis vehicle will be applied to rats for 21 days. 3rd. group: Silver Sulfadiazine group, 1% Silver Sulfadiazine will be applied topically to rats for 21 days. 4th. group: Nitrafurozon group, 0.2% Nitrafurozon will be applied topically for 21 days. 5th. group: 10% Propolis group, 10% Propolis will be applied topically for 21 days. 6th. group: 15% Propolis group, 15% Propolis will be applied topically for 21 days.
Masking:
Single (Outcomes Assessor)
Masking Description:
the researcher who will analyze the primary outcome of the study will not know which group of animals the samples were taken from.
Primary Purpose:
Treatment
Official Title:
Effect of Topical Turkish Propolis Application on Burn Healing in Experimental Burn Model
Actual Study Start Date :
Sep 1, 2020
Actual Primary Completion Date :
Sep 28, 2020
Actual Study Completion Date :
Sep 28, 2020

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Control group

It will be accepted as the control group and 4 experimental burn wounds will be created on the back of the rats in the group and no treatment will be given.

Biological: burn wound dressing
st. group: It will be considered as a control group and rats will not be treated. nd. group: Vehicle group, Propolis vehicle will be applied topically to rats for 21 days. rd group: Silver Sulfadiazine group, 1% Silver Sulfadiazine will be applied topically to rats for 21 days. th. group: Nitrafurozon group, 0.2% Nitrafurozon will be applied topically for 21 days. th. group: 10% Propolis group, 10% Propolis will be applied topically for 21 days. th. group: 15% Propolis group, 15% Propolis will be applied topically for 21 days.

Active Comparator: 1% Silver Sulfadiazine

4 experimental burn wounds will be created on the back of the rats in the group and dressing with 1% Silver Sulfadiazine will be done on the back of the rats every day for 21 days.

Biological: burn wound dressing
st. group: It will be considered as a control group and rats will not be treated. nd. group: Vehicle group, Propolis vehicle will be applied topically to rats for 21 days. rd group: Silver Sulfadiazine group, 1% Silver Sulfadiazine will be applied topically to rats for 21 days. th. group: Nitrafurozon group, 0.2% Nitrafurozon will be applied topically for 21 days. th. group: 10% Propolis group, 10% Propolis will be applied topically for 21 days. th. group: 15% Propolis group, 15% Propolis will be applied topically for 21 days.

Active Comparator: %0.2 Nitrafurozon

4 experimental burn wounds will be created on the back of the rats in the group and dressing with %0.2 Nitrafurozon will be done on the back of the rats every day for 21 days.

Biological: burn wound dressing
st. group: It will be considered as a control group and rats will not be treated. nd. group: Vehicle group, Propolis vehicle will be applied topically to rats for 21 days. rd group: Silver Sulfadiazine group, 1% Silver Sulfadiazine will be applied topically to rats for 21 days. th. group: Nitrafurozon group, 0.2% Nitrafurozon will be applied topically for 21 days. th. group: 10% Propolis group, 10% Propolis will be applied topically for 21 days. th. group: 15% Propolis group, 15% Propolis will be applied topically for 21 days.

Experimental: 10% Propolis

4 experimental burn wounds will be created on the back of the rats in the group and dressing with 10% Propolis will be done on the back of the rats every day for 21 days.

Biological: burn wound dressing
st. group: It will be considered as a control group and rats will not be treated. nd. group: Vehicle group, Propolis vehicle will be applied topically to rats for 21 days. rd group: Silver Sulfadiazine group, 1% Silver Sulfadiazine will be applied topically to rats for 21 days. th. group: Nitrafurozon group, 0.2% Nitrafurozon will be applied topically for 21 days. th. group: 10% Propolis group, 10% Propolis will be applied topically for 21 days. th. group: 15% Propolis group, 15% Propolis will be applied topically for 21 days.

Experimental: 15% Propolis

4 experimental burn wounds will be created on the back of the rats in the group and dressing with 15% Propolis will be done on the back of the rats every day for 21 days.

Biological: burn wound dressing
st. group: It will be considered as a control group and rats will not be treated. nd. group: Vehicle group, Propolis vehicle will be applied topically to rats for 21 days. rd group: Silver Sulfadiazine group, 1% Silver Sulfadiazine will be applied topically to rats for 21 days. th. group: Nitrafurozon group, 0.2% Nitrafurozon will be applied topically for 21 days. th. group: 10% Propolis group, 10% Propolis will be applied topically for 21 days. th. group: 15% Propolis group, 15% Propolis will be applied topically for 21 days.

Active Comparator: Propolis vehicle

4 experimental burn wounds will be created on the back of the rats in the group and dressing with Propolis vehicle will be done on the back of the rats every day for 21 days.

Biological: burn wound dressing
st. group: It will be considered as a control group and rats will not be treated. nd. group: Vehicle group, Propolis vehicle will be applied topically to rats for 21 days. rd group: Silver Sulfadiazine group, 1% Silver Sulfadiazine will be applied topically to rats for 21 days. th. group: Nitrafurozon group, 0.2% Nitrafurozon will be applied topically for 21 days. th. group: 10% Propolis group, 10% Propolis will be applied topically for 21 days. th. group: 15% Propolis group, 15% Propolis will be applied topically for 21 days.

Outcome Measures

Primary Outcome Measures

  1. wound size [21 days]

    photos will be taken every day to determine the wound size

  2. bulla [3rd day of the research]

    examination of the skin at the light microscopic level. Bulla will be considered as present or absent.

  3. bulla [7th day of the research]

    examination of the skin at the light microscopic level. Bulla will be considered as present or absent.

  4. bulla [14th day of the research]

    examination of the skin at the light microscopic level. Bulla will be considered as present or absent.

  5. bulla [21st day day of the research]

    examination of the skin at the light microscopic level. Erythemawill be considered as present or absent.

  6. edema [3rd day of the research]

    examination of the skin at the light microscopic level. Edema will be considered as present or absent.

  7. edema [7th day of the research]

    examination of the skin at the light microscopic level. Edema will be considered as present or absent.

  8. edema [14th day of the research]

    examination of the skin at the light microscopic level. Edema will be considered as present or absent.

  9. edema [21st day of the research]

    examination of the skin at the light microscopic level. Edema will be considered as present or absent.

  10. inflammatory cell infiltration [3rd day of the research]

    examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.

  11. inflammatory cell infiltration [7th day of the research]

    examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.

  12. inflammatory cell infiltration [14th day of the research]

    examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.

  13. inflammatory cell infiltration [21st day of the research]

    examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.

  14. necrosis [3rd day of the research]

    examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.

  15. necrosis [7th day of the research]

    examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.

  16. necrosis [14th day of the research]

    examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.

  17. necrosis [21st day of the research]

    examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.

  18. ulceration [3rd day of the research]

    examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.

  19. ulceration [7th day of the research]

    examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.

  20. ulceration [14th day of the research]

    examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.

  21. ulceration [21st day of the research]

    examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.

  22. angiogenesis [3rd day of the research]

    examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.

  23. angiogenesis [7th day of the research]

    examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.

  24. angiogenesis [14th day of the research]

    examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.

  25. angiogenesis [21st day of the research]

    examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.

  26. fibroblast proliferation [3rd day of the research]

    examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.

  27. fibroblast proliferation [7th day of the research]

    examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.

  28. fibroblast proliferation [14th day of the research]

    examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.

  29. fibroblast proliferation [21st day of the research]

    examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.

  30. epithelization [3rd day of the research]

    examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.

  31. epithelization [7th day of the research]

    examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.

  32. epithelization [14th day of the research]

    examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.

  33. epithelization [21st day of the research]

    examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.

  34. collagenization [3rd day of the research]

    examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.

  35. collagenization [7th day of the research]

    examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.

  36. collagenization [14th day of the research]

    examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.

  37. collagenization [21st day of the research]

    examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.

  38. microorganism colonization [3rd day of the research]

    examination of the skin at the light microscopic level. Colonization will be considered as present or absent.

  39. microorganism colonization [7th day of the research]

    examination of the skin at the light microscopic level. Colonization will be considered as present or absent.

  40. microorganism colonization [14th day of the research]

    examination of the skin at the light microscopic level. Colonization will be considered as present or absent.

  41. microorganism colonization [21st day of the research]

    examination of the skin at the light microscopic level. Colonization will be considered as present or absent.

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Weeks to 12 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • adult (8-12 weeks)

  • 200-300 grams

  • Wistar-Albino rat

  • with 4 second-degree superficial contact burn are at its back.

Exclusion Criteria:
  • the death of the rat in the research process

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ege University İ̇zmi̇r Turkey

Sponsors and Collaborators

  • Izmir Katip Celebi University

Investigators

  • Study Director: Figen Yardımcı, Ege University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
ESRA ARDAHAN AKGUL, Research Assistant, Izmir Katip Celebi University
ClinicalTrials.gov Identifier:
NCT04277182
Other Study ID Numbers:
  • 2019-048
First Posted:
Feb 20, 2020
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by ESRA ARDAHAN AKGUL, Research Assistant, Izmir Katip Celebi University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2022